Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,079 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of clinical pharmacy services in Australia, Austria, Belgium, Bosnia-Herzegovina, Canada, Germany, Japan, Kosovo, Switzerland, the Netherlands, Thailand, USA and correlation with educational standards, level of research, and implemen.
Rose O, Derendorf H, Erzkamp S, Fujita K, Hartl A, Hoti K, Krass I, Obarcanin E, Saevels J, Srimongkon P, Teichert M, Tsuyuki RT. Rose O, et al. Among authors: fujita k. Int J Clin Pharmacol Ther. 2018 Nov;56(11):518-530. doi: 10.5414/CP203264. Int J Clin Pharmacol Ther. 2018. PMID: 30106363
Endoplasmic reticulum transporter OAT2 regulates drug metabolism and interaction.
Arakawa H, Ishida N, Nakatsuji T, Matsumoto N, Imamura R, Shengyu D, Araya K, Horike SI, Tanaka-Yachi R, Kasahara M, Yoshioka T, Sumida Y, Ohmiya H, Daikoku T, Wakayama T, Nakamura K, Fujita KI, Kato Y. Arakawa H, et al. Among authors: fujita ki. Biochem Pharmacol. 2024 May 28;225:116322. doi: 10.1016/j.bcp.2024.116322. Online ahead of print. Biochem Pharmacol. 2024. PMID: 38815630 Free article.
A Case of Chronic Hepatitis B in which HBs Antigen Seroclearance was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-up.
Mimura S, Ono M, Fujita K, Takuma K, Nakahara M, Oura K, Tadokoro T, Tani J, Morishita A, Kagawa S, Okano K, Himoto T, Masaki T. Mimura S, et al. Among authors: fujita k. Intern Med. 2024 May 30. doi: 10.2169/internalmedicine.3643-24. Online ahead of print. Intern Med. 2024. PMID: 38811223 Free article.
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma.
Uchimoto T, Matsuda T, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Hashimoto M, Higashio T, Tsuchida S, Nishimura K, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Miki J, Fujita K, Kimura T, Ohno Y, Shiroki R, Uemura H, Azuma H. Uchimoto T, et al. Among authors: fujita k. Target Oncol. 2024 May 28. doi: 10.1007/s11523-024-01068-7. Online ahead of print. Target Oncol. 2024. PMID: 38807017
Maintenance of R-loop structures by phosphorylated hTERT preserves genome integrity.
Machitani M, Nomura A, Yamashita T, Yasukawa M, Ueki S, Fujita KI, Ueno T, Yamashita A, Tanzawa Y, Watanabe M, Taniguchi T, Saitoh N, Kaneko S, Kato Y, Mano H, Masutomi K. Machitani M, et al. Among authors: fujita ki. Nat Cell Biol. 2024 May 28. doi: 10.1038/s41556-024-01427-6. Online ahead of print. Nat Cell Biol. 2024. PMID: 38806647
5,079 results